Sitemap - 2019 - This week in Mathematical Oncology

#MathOnco Issue 95: clonal diversity, Markov chains, p-hacking, and more.

#MathOnco Issue 94: genetic instability, resistance and tolerance, cancer risk, immune recruitment, Lotka, EvoFreq

#MathOnco Issue 93: uncertainty/sensitivity in agent-based models; transmissible cancer "speciation"; fluid mechanics review in cancer; evolution

#MathOnco Issue 92: universal cancer tasks & trade-offs; game theory; systems bio; machine learning; ecological models of cancer

#MathOnco Issue 91: cancer recurrence times, the "perturbome," genotype-phenotype, clonality, metastasis, and resistance

#MathOnco Issue 90: rapid cancer evolution, clonal selection, mutator models, neoantigen heterogeneity, and parameter identifiability.

#MathOnco Issue 89: interactive sims; evolution/ecology of cancer; phylogenetic inferences; vascularized tumors; spatial structure.

#MathOnco Issue 88: immune-mediated mets, signalling networks, tissue evolution, multi-drug resistance, and genetic algorithms.

#MathOnco Issue 87: evolutionary game dynamics, acid-mediated invasion, radiotherapy, gene surfing, allee effect, sweeps.

#MathOnco Issue 86: in silico Darwinian evolution, transcriptional dynamics, genomic instability, pop genetics, and CAR-T response

#MathOnco Issue 85: invasive cancer; division rates; subclonal mutation frequency; evolutionary trajectories; CAR T-cell

#MathOnco Issue 84: cancer eco-evo; mutational distributions; personalized therapy; submit a blog post!

#MathOnco Issue 83: genetic heterogeneity, designing therapy using machine learning, deleterious mutations, and oxygenation heterogeneity

#MathOnco Issue 82: estimating heterogeneity, microenvironmental models, oncolytic virotherapy, brain mets, and immune-mediated mets.

#MathOnco Issue 81: cooperative adaptation, immunogenicity, genetic heterogeneity, logistic models, and phenotypic coexistence

#MathOnco Issue 80: modeling vs stats; tumor acidity; personalized radiotherapy; visualizing evolution

#MathOnco Issue 79: integrative approaches to immunotherapy, chemotactic tumor cells, network topology & growth laws, and cancer resistance

#MathOnco Issue 78: data-fitting, mutations/immunogeneicty, transmissible cancer, osteocyte models, and more.

#MathOnco Issue 77: cancer evolution, selection in hierarchical tissues, adaptive resistant management, and more.

#MathOnco Issue 76: modeling philosophy, mutation order, spatial constraints, blogging, and more

#MathOnco Issue 75: single-cell sequencing, neoantigen landscape, hybrid models, optimization and best fits

#MathOnco Issue 74: evolutionary selection, therapy, prediction and more!

#MathOnco Issue 73: consecutive seeding, subclonal diversity, co-evolution, hidden Markov models

#MathOnco Issue 72: first-strike/second-strike; integrated pest management; the evolution of metastases; metabolism in tumors

#MathOnco Issue 71: evolutionary games; tumor growth models; prostate cancer therapy scheduling; environmental feedbacks in evolutionary dynamics

#MathOnco Issue 70: immune-tumor interactions, optimal metastatic control, distribution of fitness effects, data integration & population models

#MathOnco Issue 69: growth dynamics, treatment dynamics, phenotypic selection, branching mutational processes, radiosensitivity

#MathOnco Issue 68: patient-specific; hack-a-thons; cancer risk; information theory classifiers

#MathOnco Issue 67: multi-scale frameworks, adaptive dynamics, plasticity, coexistence theory, ecology on phylogenetic trees

#MathOnco Issue 66: ML vs mechanism; multi-stage models; population structure; spatial competition; perseverance & grit

#MathOnco Issue 65: predicting tumor evolution; personalized cancer treatment schedules

#MathOnco Issue 64: physical sciences in oncology; heterogeneity; games & graphs

#MathOnco Issue 63: the future of math oncology; stem-cell heterogeneity, biomech. tumor-induced intracranial pressure, spontaneous/induced evolution

#MathOnco Issue 62: evolutionary extinction; angiogenesis & MRI; tumor cell infiltration; multi-drug adaptive; aging & senescence; eco-evo feedback

#MathOnco Issue 61: Markov chain models of mets; immune response modeling; multi-scale modeling; dose-response; non-cell autonomous processes

#MathOnco Issue 60: measuring heterogeneity; epithelial-mesenchymal mechanism, macrophage-driven immunoediting; metastasis evol

#MathOnco Issue 59: spatial models of tumor growth and evolution, angiogenesis, systems bio, single-cell data cell fates

#MathOnco Issue 58: clonogenicity, stem cells, game theory, homeostasis, radiation, and more

#MathOnco Issue 57: evolutionary complexity, phenotypic tradeoffs, immune-tumor interactions

#MathOnco Issue 56: immune-mediated mets; quasi birth-death; multi-region sequencing; epidermis clonality

#MathOnco Issue 55: multiscale cell-based models; microenvironmental interactions; state-of-the-art imaging with modeling; statistical mechanics

#MathOnco Issue 54: evolutionary dynamics and heterogeneity; optimal therapeutic scheduling; cell-based modeling techniques

#MathOnco Issue 53: spatial heterogeneity; pharmacokinetics modeling; measuring subclonal selection; phenotypic switching.

#MathOnco Issue 50: immune-oncology, tumor niches, dose schedules, density-dependence, evolution models

#MathOnco Issue 49: a review of cancer paradoxes, markov chains, hierarchical fitness, nonlinear adaptive control

#MathOnco Issue 48: stem cell heterogeneity, adaptive genetic diversity, ALK targeting, network control

#MathOnco Issue 47: immune perspective on chemo; system response to local therapy; evolution of cooperation;

#MathOnco Issue 46: the MathOnco 1 year anniversary

#MathOnco Issue 45: patient-specific brain tumor models; mesenchymal stem cells; circulating tumor cells; phenotypic transitions

#MathOnco Issue 52: intro to Math Onco; driver mutations; tumor heterogeneity; cellular interactions

#MathOnco Issue 44: game theory in cancer; adaptive therapy; mutational interactions; evolutionary dynamics

#MathOnco Issue 43: fitness trade-offs in tumors; dormancy mechanisms; tyrosine kinase inhibition; framework for metastatic spreading

#MathOnco Issue 42: neutral tumor evolution; cellular age distributions; migration and spreading; personalized therapy

#MathOnco Issue 23: cost of resistance, stromal macrophages & fibroblasts, evolutionary graph theory, combination immunotherapy

#MathOnco Issue 41: evolution of normal tissue; nonlinear optimization of Norton-Simon; game theory & agent-based models

#MathOnco Issue 40: immune selection & evolution; drug perfusion; cellular plasticity; fitness landscapes

#MathOnco Issue 39: quantifying tumor heterogeneity, drivers/oncogenes/tumor suppressors; population statistics on cancer genomic data.

#MathOnco Issue 38: get a PhD/PostDoc in MathOnco; universal law of cancer; RNA seq; semi-automatic ODE assembly; the dimensionality curse

#MathOnco Issue 37: evolutionary simulations; perspectives on tumor heterogeneity; super twisting sliding control

#MathOnco Issue 36: competition; fitness valleys, stem cell dynamicss; generalized evolutionary framework; tumor immunity

#MathOnco Issue 35: Hello world; cellular automata, driver gene, subclonal heterogeneity.

#MathOnco Issue 34: clonal evolution; punctuated equilibrium; 3D genome structure; recurrent jackpot events

#MathOnco Issue 33: non-genetic / genetic resistance duality, radiation immunotherapy; tumor spheroid; synergistic drugs;

#MathOnco Issue 32: maintenance treatment; properties of Wright-Fisher models; Pareto evolutionary trade-offs of driver mutations; ELECTRE methods

#MathOnco Issue 31: game theory optimizations, stem cells and EMT, somatic evolution, visualizing bio data

#MathOnco Issue 30: evolutionary dynamics of hemoglobinuria, chromosomal instability, RNA velocity of single cells, cancer hallmark acquisition

#MathOnco Issue 29: somatic event timing, causation in cancer, models of overtreatment, predictive systems biology models

#MathOnco Issue 28: are there theoretical "results?" ; mechanical and systems bio, metastatic castrate resistant prostate cancer

#MathOnco Issue 27: oncolytic virotherapy, adaptive plasticity, estimating heterogeneity/fitness, elementary flux modes

#MathOnco Issue 26: personalized neuro-oncology tools, artificial intelligence in drug regimens, cell size heterogeneity

#MathOnco Issue 25: mechanistic models vs machine learning; eco-evolution; combinatorial immunotherapies; physical interactions

#MathOnco Issue 24: multi-drug therapy resistance; go-or-grow models of glioma; metastasis models; immune response models

#MathOnco Issue 23: cost of resistance, stromal macrophages & fibroblasts, evolutionary graph theory, combination immunotherapy

#MathOnco Issue 22: negative selection; passenger mutations; tumor evolution; generalized formalisms; natural selection; model simplification

#MathOnco Issue 21: cancer as social dysfunction, purifying selection, subclonal quantification, tumor-stroma game theory, neural networks

#MathOnco Issue 20: evolution / ecology conference, resistance, glioblastoma recurrence, combo chemo, chaotic attractors, quiescence

#MathOnco Issue 19: mutational processes; spatial mutation patterns; epithelial-mesenchymal transition; Erythropoiesis; bipartite ecological networks

#MathOnco Issue 18: crowd sourcing cancer treatment, gene regulatory networks, ising models, SNPs, fitness landscape, Monte Carlo

#MathOnco Issue 17: special issue Math Bio Bulletin! Combination therapy, evolution of resistance, synergism/antagonism, virtual patients

#MathOnco Issue 16: spatial heterogeneity, mutualism diversity, multiple games evolutionary dynamics, co-evolving networks, adaptive oncogenesis

Issue 15: metabolism, bertalanffy growth, myeloma screening, chemoradiation for metastasis, in silico mouse growth kinetics, #mathonco

Issue 14: tumor associated macrophages, pharmacokinetic, pharmacodynamic, combination therapy, heterogeneity, metastasis, #mathonco

Issue 13: intra-tumoral competition, parameter estimation, model validation, memoryless cell cycle, cell interactions, Bayesian features, #mathonco

Issue 12: heterogeneity (genetic/cell signaling/microenvironment), patio-structural-temporal, invasiveness, glioma, cost of resistance, #mathonco

Issue 11: pharmacokinetics co-culture, fractionated radiotherapy, lessons in stochastic models, spatial diversity, central dogma, somatic maintenance

Issue 10: evolution of insulin resistance, eco- review, personalized computational oncology, lymphocyte kinetics, and more. #MathOnco

This Week in #MathOnco

Issue 8: EMT tristability, combinatorial treatments, drug response metrics, clonal dominance, transition state characteristics

Issue 7: spatial-nonspatial games; dormancy/criticality; niche construction; trait fixation; adaptive oncogenesis

Issue 6: Boolean methods, biased voter models, heterogeneity, homeostasis

Issue 5: Immunosuppression, evolutionary bio, complexity-aware simple modeling, control analysis, radiation with hyperthermia

Issue 4: Glioblastoma modeling, complex adaptive systems, chemo-induced resistance, multi-stage cancer models

This Week in Mathematical Oncology

#MathOnco Issue 51: Moran models, genetic instability in immune surveillance, hybrid modeling, antibiotic resistance

#MathOnco Issue 50: Moran models, genetic instability in immune surveillance, hybrid modeling, antibiotic resistance

#MathOnco Issue 50: immune-oncology, tumor niches, dose schedules, density-dependence, evolution models

#MathOnco Issue 49: a review of cancer paradoxes, markov chains, hierarchical fitness, nonlinear adaptive control

#MathOnco Issue 48: stem cell heterogeneity, adaptive genetic diversity, ALK targeting, network control